Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-929-9 | CAS number: 68391-11-7 The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150°C (302°F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Several acute toxicity studies were carried out, with key studies available for all relevant routes. Acute oral toxicity studies were carried out with Pyridine, alkyl derivs. Acute inhalation and acute dermal toxicity studies were carried out with 5-ethyl-2-methylpyridine (MEP, CAS no.: 104-90-5, EC no.: 203-250-0). The read-across between the UVCB substance and the model constituent is justified.
In a study similar or equivalent to EU Method B.1 and OECD Guideline 401 (Acute toxicity oral) the LD50 oral was determined to be 1.35 mL/kg bw (1350 mg/kg bw). In a study similar or equivalent to EU Method B.2 and OECD Guideline 403 (Acute Inhalation Toxicity) the LC50 inhalation was determined 2.67 mg/L (2670 mg/m3). In a study similar or equivalent to EU Method B.3 and OECD Guideline 402 (Acute Dermal Toxicity) the LD50 dermal was determined 1000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP study.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 190 - 220 g (males) and 140 - 160 g (females)
- Fasting period before study: Overnight fast (for 18 - 20 hours before treatment)
- Housing: Solid floor polypropylene boxes furnished with softwood sawdust
- Diet: Ad libitum
- Water: Ad libitum
- Acclimation period: Not less than 3 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 50 +/- 10
IN-LIFE DATES:
- July 1977 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED:
- All animals were treated with neat material - Doses:
- A single oral dose of test material, based on the fasted body weight of the animals at the time of treatment, was administered by gavage using a metal stomach tube. The animals were then returned to their cages for observation.
Range finding study: 1.0, 3.0 mL/kg bw
Main study: 1.0, 1.5, 2.0, 2.5 and 5.0 mL/kg bw - No. of animals per sex per dose:
- Range finding study: 2 male/2 female animals per dose
Main study: 5 male/5 female animals per dose - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed for overt toxicity at 0.25, 1, 2 and 4 hours after treatment and subsequently once daily for 14 days, body weights of survivors were recorded at 7 and 14 days after treatment.
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical signs, gross necropsy - Statistics:
- Litchfield and Wilcoxon (A simplified method for the evaluation of dose effect experiments, J. Pharm. Exp. Therap. 96, 99, (1949).
- Preliminary study:
- Two groups each of 4 fasted rats (2 males, 2 females) were dosed with 1.0 and 3.0 mL/kg bw. Mortalities were recorded at daily intervals for the following 7 days.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1.55 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 1.4 - 1.72
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1.35 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 1.1 - 1.66
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1.42 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 1.19 - 1.69
- Mortality:
- For determination of the formal LD50 twenty-six mortalities occurred during the study, 23 of which were within 24 hours of treatment. One mortality of a high dose male was observed within 4 hours and of 1 high dose female 48 hours after treatment. For one male rat dosed with 1.5 mL/kg bw mortality was noted 4 days after treatment.
- Clinical signs:
- All animals appeared subdued and lethargic within 15 minutes of treatment; this behaviour was not apparent at 24 hours. All survivors throughout dose groups showed dull staring coats, laboured respiration and hunched posture within 24 hours of treatment. All rats were asymptomatic at 72 hours.
- Body weight:
- All male survivors showed normal gains in body weight throughout the 14 day observation period. The low dose female survivors showed small body weight gains during the 14 day observation period. The female survivors dosed with 1.5 mL/kg bw showed loss in body weight at the 7 day observation and a very small increase in body weight at 14 days.
- Gross pathology:
- Gross necropsy of all animals (mortalities and survivors) showed no detectable abnormalities.
- Other findings:
- None.
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the results obtained in this acute toxicity study the LD50 value obtained for males was 1.55 mL/kg bw (1.40 - 1. 72) for females 1.35 mL/kg bw (1.10 - 1. 66) and for males/females 1.42 mL/kg bw (1.19 - 1.69).
- Executive summary:
A study was carried out equivalent or similar to EU Method B.1 and OECD Guideline 401 (Acute Oral Toxicity). Following a dose-range finding study, 5 groups of 10 rats (5 male, 5 female) of the Sprague Dawley strain were treated with a single oral dose of test item within the dose range 1.0 - 5.0 mL/kg bw. A log dose-mortality curve was constructed and the acute oral LD50 and 95 % fiducial limits calculated by the method of Litchfield and Wilcoxon. The LD50 value obtained for males was 1.55 mL/kg bw (1.40 - 1. 72) for females 1.35 mL/kg bw (1.10 - 1. 66) and for males/females 1.42 mL/kg bw (1.19 - 1.69).
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 350 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 2 670 mg/m³
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 000 mg/kg bw
Additional information
Key study: Acute toxicity – oral
A study was carried out equivalent or similar to EU Method B.1 and OECD Guideline 401 (Acute Oral Toxicity). Following a dose-range finding study, 5 groups of 10 rats (5 male, 5 female) of the Sprague Dawley strain were treated with a single oral dose of test item within the dose range 1.0 - 5.0 mL/kg bw. A log dose-mortality curve was constructed and the acute oral LD50 and 95 % fiducial limits calculated by the method of Litchfield and Wilcoxon. The LD50 value obtained for males was 1.55 mL/kg bw (1.40 - 1. 72) for females 1.35 mL/kg bw (1.10 - 1. 66) and for males/females 1.42 mL/kg bw (1.19 - 1.69).
Supporting study 1: Acute toxicity – oral
A study was carried out equivalent or similar to EU Method B.1 and OECD Guideline 401 (Acute Oral Toxicity). A total of 7 groups of 10 young adult Albino rats (5 male, 5 female) were treated with a single oral dose of test item within the dose range 1.0 - 4.0 mL/kg bw. Based on the results obtained in this acute toxicity study the LD50 for males obtained was 1.94 mL/kg bw (95 % CL 1.67 - 2.24) and for females 2.46 mL/kg bw day (95 % CL 2.0 - 3.03).
Supporting study 2: Acute toxicity – oral
A study was carried out equivalent or similar to EU Method B.1 and OECD Guideline 401 (Acute Oral Toxicity). A total of 8 groups of 10 young adult Albino rats (5 male, 5 female) were treated with a single oral dose of test item within the dose range 1.0 - 8.0 mL/kg bw. Based on the results obtained in this acute toxicity study the LD50 for males obtained was 3.25 mL/kg bw (95 % CL 2.1 - 5.0) and for females 3.1 mL/kg bw day (95 % CL 2.7 - 3.6).
Supporting study 3: Acute toxicity – oral
A study was carried out equivalent or similar to EU Method B.1 and OECD Guideline 401 (Acute Oral Toxicity). A total of 5 groups of 10 Wistar rats (5 male, 5 female) were treated with a single oral dose of test item within the dose range 1.0 – 3.2 mL/kg bw. Based on the results obtained in this acute toxicity study the LD50 for males and females was 1.67 mL/kg bw day (95 % CL 1.28 - 2.17).
Key study: Acute toxicity – inhalation
Determination of acute inhalation toxicity was carried out with 5-ethyl-2-methylpyridine (MEP, CAS no.: 104-90-5, EC no.: 203-250-0). The read-across between the UVCB substance and the model constituent is justified. A study similar or equivalent to EU Method B.2 and OECD Guideline 403 (Acute Inhalation Toxicity) was carried out. Rats were dosed for 4 hours. An LC50 of 2.67 mg/L was obtained.
Key study: Acute toxicity – dermal
Determination of acute dermal toxicity was carried out with 5-ethyl-2-methylpyridine (MEP, CAS no.: 104-90-5, EC no.: 203-250-0). The read-across between the UVCB substance and the model constituent is justified. A study similar or equivalent to EU Method B.3 and OECD Guideline 402 (Acute Dermal Toxicity) was carried out. Rabbits were administered a single dermal dose. An LD50 of 1000 mg/kg bw was revealed.
Justification for classification or non-classification
Based on the data available the substance is classified and labeled according to Regulation 1272/2008/EEC (CLP) as Acute toxicity category 4, Oral H302 Harmful if swallowed, acute toxicity category 3, Dermal H311 Toxic in contact with skin, acute toxicity category 3, Inhalation H331 Toxic if inhaled and Xn harmful, R20/21/22 Harmful by inhalation, in contact with skin and if swallowed according to Directive 67/548/EEC (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.